Gregory Fraser of Truist Securities, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $52 to $60 on, Jul 21st, 2023.
Gregory has made no other calls on ANIP in the last 4 months.
There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Gregory's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Gregory
- Elliot Wilbur of "Raymond James" Maintained at Buy with Increased Target to $49 on, Tuesday, May 9th, 2023
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $60 on, Tuesday, May 9th, 2023
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $59 on, Tuesday, May 9th, 2023
